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Abstract
Background: Postoperative pain has many adverse effects and if not properly controlled, it can cause a wide range of problems.
Objectives: The purpose of this study is to compare the results of using ketamine and apotel infusion pumps to control pain after
posterior fusion surgery.
Methods: In this clinical trial study, 72 patients hospitalized for posterior spine fusion surgery were randomly assigned into two
groups, including ketamine infusion pumps (ketamin group) and apotel infusion pumps (apotel group). In the ketamin group, 0.2
mg/kg/h of ketamine was infused to by a pain pump with normal saline to 100 cc. In the apotel group, apotel was used instead of
ketamine. The rate of pain was evaluated in recovery, and at 6, 12, 18, 24, and 48 hours after the surgery, based on VAS criteria. The
rate of sedation was recorded based on Ramsy score.
Results: There was no significant difference between age, sex, BMI, underlying diseases, and smoking in patients with posterior
spinal fusion surgery between the groups. Postoperative pain score was significantly lower in the patients with posterior fusion
surgery at 6, 12, 18, 24, and 48 hours in the ketamin group compared to the apotel group (P < 0.001). Patients’ satisfaction with the
analgesia was significantly higher in the patients at 24 hours (P = 0.001) and 48 hours (P = 0.04) in the ketamine group compared
to the apotel. With regards to the Ramsy scores of the patients with posterior fusion surgery, there was no significant difference
between the groups (P = 0.16).
Conclusions: The use of a ketamine infusion pump can be more effective than an apotel infusion pump to control pain after poste-
rior fusion surgery.
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1. Background
Postoperative pain has many adverse effects on the pa-
tient. If not controlled properly, it can lead to a wide range
of problems, such as pneumonia, DVT, infections, cardiac
ischemia, and skin ulcers, and may even become a chronic
symptom (1).
The use of a pain pump is an appropriate method for
relieving postoperative pain. Using opioids for pain con-
trol can cause a wide range of complications, such as nau-
sea and vomiting, respiratory depression, sedation, and in-
tolerance; in this regard, adjuvant drugs have been intro-
duced to reduce the need for opioids and improve the qual-
ity of analgesia (2). They can be helpful, especially in pa-
tients with a history of narcotic use; they show little re-
sponse to the opioids and, therefore, need a higher dose of
the pain control drugs, which deteriorates the symptoms.
In general, the approach to the pain pump and multi-
drug combination, which have fewer complications, has
increased attention to adjuvant drugs (3).
Today, vein acetaminophen with apotel brand as an ad-
juvant drug is one of the most commonly used drugs to
control pain in operating rooms and inpatients.
Furthermore, apotel is an antiemetic drug which acts
by the prevention of the secretion of prostaglandins in the
CNS; prostaglandins have a direct effect on the Tempera-
ture Control Center in the hypothalamus which in turn re-
sulted in the reduction of the anti-inflammatory effects of
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the environment, as well as reduction of fever. Overall, apo-
tel is used to control short-term pains with mild to moder-
ate strength, especially after surgery, hyperthermia treat-
ment, and emergency pain management (4).
Research shows that ketamine is a fast-acting anes-
thetic used for anesthetic, tranquil, and analgesic; it has
high safety margins with an antagonistic effect on the
NMDA receptor; the latter prevents CNS sensitivity to
painful stimuli, and reduces in postoperative pain (5).
Ketamine has not been used for a long time for pain
control, due to its possible complications, such as neuro-
toxicity, delirium, and its negative effects on memory. Ow-
ing to new studies which have clearly shown the mecha-
nism of action and effects of relieving pain and analgesia
at low doses, apotel is now considered again as the part of
a multidrug approach in almost all surgical spectra (6-11).
Postoperative pain can be a serious problem in patients un-
dergoing spinal fusion surgery, because it may bring about
extensive damage to the soft tissue, bones, and muscles.
The present study compared the analgesic efficacy and
safety of intravenous ketamine infusion for pain manage-
ment with intravenous infusion apotel in spondylolisthe-
sis who underwent lumbar spinal fusion. The instrumen-
tation was also evaluated (12).
2. Objectives
Accordingly, this study provides a comparative analy-
sis of the effects of ketamine and apotel in pain pump on
controlling the postoperative pain in posterior spine fu-
sion surgery.
3. Methods
Approved by the Ethics Committee of Iran Univer-
sity of Medical Sciences under the register code of
IRCT20190430043430N1, the present study was con-
ducted under a double-blind randomized clinical trial
environment.
It consisted of 72 patients hospitalized in 2018 for pos-
terior spinal fusion surgery. The samples were selected
through a convenient sampling technique. All the partic-
ipants met the inclusion criteria.
To calculate the sample size, we used the formula pro-
vided by Kaur (13): assuming a difference of 2 in the VAS
score of 6 hours after the surgery in the two groups (6 and
4) and the standard deviation of 3, alpha 0.05, and the test
power of 80%, the below formula provided the sample size










Neither the evaluator nor the patients were aware of
the type of intervention. The patients were randomly di-
vided into two groups by a third person who was not famil-
iar with the design selecting envelopes for the groups.
3.1. Inclusion Criteria
Participants’ age range of 20 - 50 years old, ASA2-1, non-
addiction and non-smoking, BMI < 35. They were asked to
sign the consent form.
3.2. Exclusion Criteria
Patients with a history of seizure, psychosis, and mem-
ory disorders were excluded from the study.
The included patients were subjected to general anes-
thesia under the anesthetic method with midazolam anes-
thesia 0.02 mg/kg and fentanyl 3 µg/kg; they underwent
standard monitoring, including electrocar diogram pulse
oximetry, and blood pressure measuring. Also, the patients
were hydrated with an infusion of 5 mL/kg of 0.9% saline.
The blood transfusions and fluid therapy were calculated
via standard methods and induction with thiopental 5
mg/kg and cisatracurium 0.2 mg/kg and lidocaine 1 mg/kg
and under maintenance with 100 µg/kg propofol and 0.1
µm fentanyl. In the operating room, after extubation, for
the ketamin group, 0.2 mg/kg of ketamine per hour was in-
fused by a pain pump. If the pain persisted, the dose was re-
peated; if persisted again, the pain was controlled by mor-
phine. To identify the side effects of ketamine, midazolam
was used. The pain score was recorded based on VAS cri-
teria from 1 to 10 points. In the apotel group, apotel was
used instead of ketamine. If the pain persisted, pethidine
and morphine were used similar to those in the ketamine
group.
The pain pump was adjusted to 4 CC infusion per hour.
The total dose of opioids was recorded in 48 hours, consid-
ering the patients’ weight.
The outcome measures encompassed VAS, the severity
of sedation, and the patients’ satisfaction with the postop-
erative analgesia. Finally, at the times of 6, 12, 18, 24, and
48 hours after the surgery, the severity of pain was mea-
sured by the Visual Analogue scale (VAS) (14); the scores was
recorded by a third person who was unaware of the study
design. The severity of sedation was measured using the
Ramasy score (15). Patients’ satisfaction with the postoper-
ative analgesia was also measured.
A simple random number generator was used for ran-
dom allocations and measurements. Throughout the trial,
researchers and nurses were blinded to the procedure
wherever applicable. Moreover, the patients were allo-
cated by a medical doctor who was not aware of the study
design that was the one who recorded the variables and
measurements.
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3.3. Data Analysis
The data were analyzed running SPSS software. To re-
port the quantitative variables, the mean ± SD was used.
For the qualitative variables, the frequency and percent
was used. For a comparative analysis of the quantitative
variables in the two normally distributed groups, the t-test
was utilized. For the qualitative variables, the chi-square
test and nonparametric tests were used. In order to com-
pare the changes in pain score in different postoperative
hours in the two groups, repeated measures ANOVA test
was used. A P value less than was considered significant.
4. Results
One pair of the samples with a total size of 72 patients,
referred to the hospital in 2018 to undergo posterior spine
fusion surgery, participated in the study. Half of the partic-
ipants were assigned to the ketamine group and the other
half were allocated to the apotel group.
The demographic data of the patients in the two
groups are provided in Table 1. Accordingly, no significant
differences were found in the two groups.
Table 1. Demographic Data in Terms of Two Groupsa
Variable Apotel (N = 36) Ketamine (N = 36) P Value




BMI, kg/m2 24.39 ± 1.94 24.14 ± 1.94 0.62
Cigarette smoking 12 (33.3%) 7 (19.4%) 0.28
aValues are expressed as mean ± SD.
As shown in Figure 1, the mean score of the postopera-
tive pain was lower in the ketamine group; this difference
was statistically significant (P < 0.001).
According to Table 2, there was no significant differ-
ence between the postoperative pain score of the surgery
in the two groups in recovery (P = 0.125). The post opera-
tive pain was significantly lower in the patients in the ke-
tamine group than the apotel group (P < 0.001) at 6, 12, 18,
24 and 48 hours after the surgery.
Table 3 shows that Ramsy score of the patients in two
groups were not, significantly different (P = 0.16).
Table 4 shows the satisfaction rate of the patients with
the analgesia in the two groups at 24 and 48 hours after
the surgery. The satisfaction rate was significantly higher





















Recovery 6 12 18 24 48
Figure 1. Comparison of pain score changes in different times in two groups
Table 2. Visual Analog Scale in Terms of Two Groupsa
Variable Apotel (N = 36) Ketamine (N = 36) P Value
Visual Analog scale
Recovery 8.75 ± 0.9 8.38 ± 0.96 0.12
6 hour after
operation
7.44 ± 0.93 6.13 ± 1.07 < 0.001
12 hours after
operation
6.58 ± 1.1 3.5 ± 1.2 < 0.001
18 hours after
operation
3.44 ± 0.55 1.88 ± 0.78 < 0.001
24 hours after
operation
2.52 ± 0.6 1.38 ± 0.59 < 0.001
48 hours after
operation
1.69 ± 0.46 1.11 ± 0.31 < 0.001
aValues are expressed as mean ± SD.
Table 3. Ramsy Score in Terms of Two Groupsa











25 (69.4) 30 (83.3)
aValues are expressed as No. (%).
Nausea and vomiting, delusions, and other complica-
tions were not observed in any of the two groups. Figure 2
shows algorithmic steps for the process of sampling.
5. Discussion
Uncontrolled pain can influence the patient and cause
various short-term and long-term problems, such as poor
patient satisfaction, development of chronic pain syn-
dromes, delayed postoperative recovery and patient mobi-
lization, vein thrombosis, pulmonary embolism, psycho-
Shiraz E-Med J. In Press(In Press):e96751. 3
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Below Shows Algorithmic Steps for the Process of Sampling 
Assessed for eligibility (n = 80 ) 
Excluded (n = 7) 
∎ Not meeting inclusion criteria (n = 3) 
∎ Declined to participate (n = 5) 
∎ Other reasons (n = 0) 
Randomized (n = 72) 
Allocated to intervention (n = 36) 
∎Received ketamin 
∎Did not receive allocated intervention (give 
       reasons) (n = 0) 
Allocated to intervention (n = 36) 
∎Received Apotel 
∎Did not receive allocated intervention (give 
       reasons) (n = 0 ) 
Lost to follow-up (give reasons) (n = 0) 
Discontinued intervention (give reasons) (n = 0) 
Lost to follow-up (give reasons) (n = 0) 
Discontinued intervention (give reasons) (n = 0) 
Analysed (n = 36) 
∎Excluded from analysis (give reasons) (n = 0) 
Analysed (n = 36) 
∎Excluded from analysis (give reasons) (n = 0) 
Figure 2. Algorithmic steps for the process of sampling
Table 4. Patients’ Satisfaction in Two Groupsa
Apotel (N = 36) Ketamine (N = 36) P Value
24 hours 0.001
Good 13 (36.1) 28 (77.8)
Moderate 20 (55.6) 8 (22.2)
Bad 3 (8.3) 0 (0)
48 hours 0.04
Good 32 (88.9) 36 (100)
Moderate 4 (11.1) (%
Bad (% 0 (0)
aValues are expressed as No. (%).
logical trauma, and ischemia. The most important find-
ing of the present meta-analysis was that the intravenous
ketamine infusion was associated with a significant reduc-
tion of postoperative pain compared with apotel infusion
(P < 0.001). There was no significant difference between
age, sex, BMI, underlying diseases, smoking in patients
with posterior spinal fusion surgery in the two groups of
ketamine and apotel. The minimum and maximum age
were 15 and 69 years, respectively. The mean age of the pa-
tients was 6.63 ± 13.18 years in the apotel group and 43.83
± 11.39 in the ketamine group. The finding showed no sig-
nificant difference between the two groups in terms of age
(P = 0.14). Out of 36 patients in the apotel group, 14 cases
were women, and 22 were men. There were ten women and
26 men in the ketamine group. Furthermore, there was
no significant difference between the two groups in terms
of gender (P = 0.474). The results showed that the postop-
erative pain at 6, 12, 18, 24 and 48 hours after the surgery
in the ketamine group was significantly lower than that
of the apotel group. Also, the pain in both of the groups
significantly decreased during recovery to 48 hours after
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the surgery. The rate of satisfaction with the analgesia
in the patients, 24 and 48 hours postoperatively, in the
ketamine group was significantly better than the apotel
group. However, there was no significant difference be-
tween the Ramsy score of the patients in the two groups.
No adverse effects of nausea, vomiting, delusion, and
other complications were found in ketamine and apotel
groups.
The incidence of the pain in the patients undergoing
posterior spine infusion surgery was relatively common;
however, it was necessary to use a more extensive range
of postoperative analgesic methods. Therefore, it is neces-
sary to consider the conventional methods of postopera-
tive analgesia (1, 2).
According to some reviews, the administration of ke-
tamine and apotel can help control the amount of the
pain after various surgeries (13, 16-18). T the best of our
knowledge, no study has yet compared ketamine infusion
pumps and applet fusion pumps for pain control after pos-
terior spine fusion surgery. Kaur et al. (13) showed that
the pain score in the first six hours after surgery in pa-
tients with open-ended cholecystectomy, under general
anesthesia in low-dose ketamine infusion (0.2 mg/kg) dur-
ing the surgery, was less than normal saline infusion (con-
trol group). At 12 and 24 hours after the surgery, there was
no significant difference between the two groups. Mor-
phine consumption in the ketamine group was lower than
that in the control group. None of the patients had side ef-
fects, and the incidence of nausea and vomiting and satis-
faction was similar in both groups.
A study by Faiz et al. (19) concluded that the pain level
of the patients undergoing hysterectomy surgery, based
on VAS criteria for recovery and 4, 6, 12, and 24 hours
after the surgery in the group of 15 mg/kg venotic ac-
etaminophen, was lower than 0.15 mg/kg ketamine group.
This inconsistency could be due to the difference in the
design and the type of surgery in the two studies. While
in other studies with results consistent with the present
study, there has been no significant difference between the
Ramsy score of the patients in recovery and 4, 6, 12, and 24
hours after the surgery regarding side effects such as nau-
sea and vomiting, respiratory problems; the drowsiness
was not significantly different between the two groups.
Pestieau et al. (18) showed that pain, sedation score,
and postoperative opioid use in pediatric patients with
scoliosis in posterior spine fusion surgery in a low dose ke-
tamine infusion group was similar with those in the saline
group. Despite the insignificance of difference, Kim et al.
(4), the results showed that the pain level was less than nor-
mal saline within 1 - 48 hours based on VAS in the patients
undergoing surgery due to posterior spine inflammation
in either ketamine (2 µg/kg/min or µg/kg/min 1, after a 0.5
to 0.5 µg/kg/min bolus dose). Moreover, there was no dif-
ference between the patients receiving ketamine and nor-
mal saline in terms of patient satisfaction and side effects.
Hadi et al. (17) showed that pain levels were significantly
lower in patients who received intravenous ketamine (1
µg/kg/min) 6, 12, and 24 hours after microedisecctomy in
the ketamine recipient group (1 µg/kg/min) during and af-
ter the surgery. Also, pain in both groups of ketamine was
lower than the normal saline group. The incidence of com-
plications of nausea and vomiting in the control group was
more than that of the two groups of ketamine. In a study
by Mahmoodiyeh et al. (20) whose results were inconsis-
tent with our results, the pain levels were observed in the
patients undergoing surgery based on VAS criteria in recov-
ery at 2, 6, and 12 hours, postoperatively, The controls were
given fentanyl/ketamine (12 mg/kg and 3.6 mg/kg, respec-
tively), and for the case group, fentanyl /paracetamol (12
mg/kg and 10 mg/kg, respectively) were used, applying by
infusion pump. Only at 24 hours was postoperative pain
in the paracetamol group less than in the ketamine group.
However, there was neither significant difference nor side
effects between hemodynamic changes in recovery and 2,
6, 12, and 24 hours after the surgery.
Ketamine has been used as a general anesthetic and
analgesic for various pain conditions in the last few
decades. Since Foster and Fagg reported the discovery of
the NMDA receptor in 1987, ketamine has been used as a
potentially antihyperglycemic agent due to its actions as
a non-competitive NMDA receptor antagonist. However,
given the adverse effects of its complications, the drug re-
mains controversial (21).
The most blatant limitation in this study was the fact
that the surgery should have been conducted by one sur-
geon, and with the same method, but it was not possible
to do at this center.
5.1. Conclusions
The use of ketamine infusion pump is more effective
than apotel infusion pump for controlling the postopera-
tive pain in posterior spinal fusion surgery.
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